RB1 and neuroendocrine carcinoma: The GEP-NEC cell line NT-32 showed a BRAF gain of function mutation (c.1457_1471del), whereas a frameshift mutation was detected in the RB1 gene (c.1696-8_1699del) and stop codon mutation was detected in the TP53 gene (c.586C > T).